US 11,744,849

Application 18/115,897 · Granted Sep 5, 2023

Hydroxypropyl beta-cyclodextrin compositions and methods

Estimated expiration

June 9, 2036

9y 203d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jun 9, 2016
+ 20 years
Jun 9, 2036
PTA +0d
Jun 9, 2036
TD cap (US 9,675,634)
Jun 9, 2036
Final
Jun 9, 2036

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
March 1, 2023
Earliest effective filing
June 9, 2016
Issue date
September 5, 2023
PTA
0 days
Base expiry (before PTA)
June 9, 2036

June 9, 2016 + 20 years = June 9, 2036

  • Continuation of application 17/970,080, filed Oct 20, 2022, issued as US 11,938,144
  • Continuation of application 17/745,464, filed May 16, 2022, issued as US 11,590,159
  • Continuation of application 17/036,148, filed Sep 29, 2020, issued as US 11,406,657
  • Continuation of application 16/430,664, filed Jun 4, 2019, issued as US 10,933,083
  • Continuation of application 16/372,899, filed Apr 2, 2019, issued as US 10,709,730
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 16/372,899, filed Apr 2, 2019, issued as US 10,709,730
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 16/430,664, filed Jun 4, 2019, issued as US 10,933,083
  • Continuation of application 16/372,899, filed Apr 2, 2019, issued as US 10,709,730
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 17/036,148, filed Sep 29, 2020, issued as US 11,406,657
  • Continuation of application 16/430,664, filed Jun 4, 2019, issued as US 10,933,083
  • Continuation of application 16/372,899, filed Apr 2, 2019, issued as US 10,709,730
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • Continuation of application 17/745,464, filed May 16, 2022, issued as US 11,590,159
  • Continuation of application 17/036,148, filed Sep 29, 2020, issued as US 11,406,657
  • Continuation of application 16/430,664, filed Jun 4, 2019, issued as US 10,933,083
  • Continuation of application 16/372,899, filed Apr 2, 2019, issued as US 10,709,730
  • Continuation of application 16/134,028, filed Sep 18, 2018, issued as US 10,300,086
  • Continuation of application 15/499,831, filed Apr 27, 2017, issued as US 10,258,641
  • Continuation of application 15/288,876, filed Oct 7, 2016, issued as US 9,675,634
  • Continuation of application 15/178,153, filed Jun 9, 2016
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term
  • PRO62/345,721 — Provisional — not used for base term
  • PRO62/331,385 — Provisional — not used for base term
  • PRO62/314,765 — Provisional — not used for base term
  • PRO62/308,736 — Provisional — not used for base term
  • PRO62/276,728 — Provisional — not used for base term
  • PRO62/263,599 — Provisional — not used for base term
  • PRO62/249,876 — Provisional — not used for base term
  • PRO62/245,974 — Provisional — not used for base term
  • PRO62/189,114 — Provisional — not used for base term
  • PRO62/175,075 — Provisional — not used for base term
  • PRO62/173,889 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to June 9, 2036 (earliest expiring referenced patent: US 9,675,634)

  • US 9,675,634· Application 15/288,876Capping patent

    Hydroxypropyl beta-cyclodextrin compositions and methods

    Filing date
    Oct 7, 2016
    Earliest effective filing
    Jun 9, 2016
    Issue date
    Jun 13, 2017
    PTA
    0 days
    Calculated expiration
    Jun 9, 2036

    Continuation of 15/178,153, filed Jun 9, 2016

    Jun 9, 2016 + 20y = Jun 9, 2036

  • US 11,744,850· Application 18/115,901(from application 18/115,901)

    Hydroxypropyl beta-cyclodextrin compositions and methods

    Filing date
    Mar 1, 2023
    Earliest effective filing
    Jun 9, 2016
    Issue date
    Sep 5, 2023
    PTA
    0 days
    Calculated expiration
    Jun 9, 2036

    Continuation of 17/970,080, filed Oct 20, 2022, issued as US 11,938,144

    Continuation of 17/745,464, filed May 16, 2022, issued as US 11,590,159

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 17/745,464, filed May 16, 2022, issued as US 11,590,159

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Jun 9, 2016 + 20y = Jun 9, 2036

  • US 11,865,136· Application 18/115,898(from application 18/115,898)

    Hydroxypropyl beta-cyclodextrin compositions and methods

    Filing date
    Mar 1, 2023
    Earliest effective filing
    Jun 9, 2016
    Issue date
    Jan 9, 2024
    PTA
    +32 days
    Calculated expiration
    Jul 11, 2036

    Continuation of 17/970,080, filed Oct 20, 2022, issued as US 11,938,144

    Continuation of 17/745,464, filed May 16, 2022, issued as US 11,590,159

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Continuation of 17/745,464, filed May 16, 2022, issued as US 11,590,159

    Continuation of 17/036,148, filed Sep 29, 2020, issued as US 11,406,657

    Continuation of 16/430,664, filed Jun 4, 2019, issued as US 10,933,083

    Continuation of 16/372,899, filed Apr 2, 2019, issued as US 10,709,730

    Continuation of 16/134,028, filed Sep 18, 2018, issued as US 10,300,086

    Continuation of 15/499,831, filed Apr 27, 2017, issued as US 10,258,641

    Continuation of 15/288,876, filed Oct 7, 2016, issued as US 9,675,634

    Continuation of 15/178,153, filed Jun 9, 2016

    Jun 9, 2016 + 20y + 32d PTA = Jul 11, 2036

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/115,897 · US 11,744,849

PatentReply compiles the prosecution history behind US 11,744,849: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11744849

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.